Latest NewsFDA NewsAdverse Event ManagementSupportive CareDisparities in Cancer CareDrug SafetyRadiation OncologySurvivorship Practice ManagementPreventionContributorsSponsored
Expert ConnectionsMorning RoundsThe VitalsPodcastsVideosBetween the LinesFrom All AnglesMeeting of the MindsTraining Academy
Conference CoverageConference Listing
Publications
Continuing Education
Case-Based Digest Rx Road MapWebinarsCancer Summary SlidesMPN Symptom ManagementEvents
SubscribePartners
Brain Cancer
Breast CancerBreast Cancer
Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
Genitourinary CancerGenitourinary CancerGenitourinary CancerGenitourinary Cancer
Gynecologic CancersGynecologic CancersGynecologic CancersGynecologic Cancers
Head and Neck Cancers
HematologyHematologyHematologyHematologyHematologyHematology
Lung Cancer
Pediatric Cancer
Sarcomas
Skin CancerSkin Cancer
Advanced Practice Corner Logo
    Brain Cancer
    Breast CancerBreast Cancer
    Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
    Genitourinary CancerGenitourinary CancerGenitourinary CancerGenitourinary Cancer
    Gynecologic CancersGynecologic CancersGynecologic CancersGynecologic Cancers
    Head and Neck Cancers
    HematologyHematologyHematologyHematologyHematologyHematology
    Lung Cancer
    Pediatric Cancer
    Sarcomas
    Skin CancerSkin Cancer
    Advanced Practice Corner Logo
        • Publications
        • Subscribe
        • Partners
      Advertisement

      Tara Sanft Explores VEGF as a Link Between Diabetes and Cancer

      June 16, 2016
      By Tara Sanft, MD
      Video

      Tara Sanft, MD, Yale Cancer Center, discusses VEGF as a possible link between diabetes and cancer.

      Tara Sanft, MD, Yale Cancer Center, discusses VEGF as a possible link between diabetes and cancer.

      VEGF promotes blood vessel formation known to play a role in breast cancer tumor formation. It is also prominent in conditions such as diabetes, which also has a link to cancer. Sanft led a study that measured VEGF levels in patients before and after implementing lifestyle changes (including diet and exercise) and found that there was a significant decrease in the growth factor after the change.

      Sanft hopes to use these results, as well as future studies on a larger scale, to find out the mechanisms as to why obesity is linked to the development of breast cancer.

      Newsletter

      Stay up to date on recent advances in oncology nursing and patient care.

      Subscribe Now!
      Recent Videos
      Photo of a woman wearing a blazer and a colorful scarf in front of a blue background
      Photo of a woman with red hair and glasses wearing a black blouse and cross necklace in front of a dark blue background
      Photo of a man wearing a suit with a blue tie in front of a dark blue background
      4 experts in this video
      Related Content

      graphic of a person with breast tumors

      JSKN003 Shows Activity in Heavily Pretreated HER2+ Breast Cancer

      Chris Ryan
      July 28th 2025
      Article

      Pooled data from early-phase trials suggest JSKN003 is tolerable and active in patients with heavily pretreated HER2-positive disease.


      Improving The Rate Of Accurate Inflammatory Breast Cancer Diagnoses

      Improving The Rate Of Accurate Inflammatory Breast Cancer Diagnoses

      Lindsay Fischer
      October 2nd 2023
      Podcast

      Ryan Tamargo, NP, AONCP, discusses the launch of an online inflammatory breast cancer scoring system tool.


      Graphic of a breast with a tumor

      Real-World Data Tie Early Breast Cancer ctDNA to Recurrence, Lower OS

      Jax DiEugenio
      July 14th 2025
      Article

      Data from a research database link ctDNA positivity in early breast cancer with poorer survival and higher recurrence risk.


      The Vitals

      Nurse Practitioners Weigh in on Data From the San Antonio Breast Cancer Symposium

      Lindsay Fischer
      January 16th 2023
      Podcast

      Loyda Braithwaite, MSN, RN, AGPCNP-BC, AOCNP; and Jamie Carroll, APRN, CNP, MSN, highlight presentations from the 2022 San Antonio Breast Cancer Symposium that will influence oncology nursing practice.


      graphic of a breast with a tumor

      KN026/KN046 Combo Yields Durable Responses in HER2+ mBC

      Jax DiEugenio
      July 7th 2025
      Article

      KN026 plus KN046 produced sustained responses and showed a manageable safety profile in pretreated patients with HER2-positive advanced breast cancer.


      Graphic of a breast with tumors

      Gedatolisib Combos Show Early Activity in mCRPC, Metastatic Breast Cancer

      Tim Cortese
      July 3rd 2025
      Article

      Gedatolisib-based combinations yielded encouraging responses in patients with mCRPC and HER2-positive metastatic breast cancer, early trial data show.

      Related Content

      graphic of a person with breast tumors

      JSKN003 Shows Activity in Heavily Pretreated HER2+ Breast Cancer

      Chris Ryan
      July 28th 2025
      Article

      Pooled data from early-phase trials suggest JSKN003 is tolerable and active in patients with heavily pretreated HER2-positive disease.


      Improving The Rate Of Accurate Inflammatory Breast Cancer Diagnoses

      Improving The Rate Of Accurate Inflammatory Breast Cancer Diagnoses

      Lindsay Fischer
      October 2nd 2023
      Podcast

      Ryan Tamargo, NP, AONCP, discusses the launch of an online inflammatory breast cancer scoring system tool.


      Graphic of a breast with a tumor

      Real-World Data Tie Early Breast Cancer ctDNA to Recurrence, Lower OS

      Jax DiEugenio
      July 14th 2025
      Article

      Data from a research database link ctDNA positivity in early breast cancer with poorer survival and higher recurrence risk.


      The Vitals

      Nurse Practitioners Weigh in on Data From the San Antonio Breast Cancer Symposium

      Lindsay Fischer
      January 16th 2023
      Podcast

      Loyda Braithwaite, MSN, RN, AGPCNP-BC, AOCNP; and Jamie Carroll, APRN, CNP, MSN, highlight presentations from the 2022 San Antonio Breast Cancer Symposium that will influence oncology nursing practice.


      graphic of a breast with a tumor

      KN026/KN046 Combo Yields Durable Responses in HER2+ mBC

      Jax DiEugenio
      July 7th 2025
      Article

      KN026 plus KN046 produced sustained responses and showed a manageable safety profile in pretreated patients with HER2-positive advanced breast cancer.


      Graphic of a breast with tumors

      Gedatolisib Combos Show Early Activity in mCRPC, Metastatic Breast Cancer

      Tim Cortese
      July 3rd 2025
      Article

      Gedatolisib-based combinations yielded encouraging responses in patients with mCRPC and HER2-positive metastatic breast cancer, early trial data show.

      Latest Conference Coverage

      Sonrotoclax/Zanubrutinib Generates Durable Response in R/R MCL

      Q&A: Nursing Considerations From Immune Cell Effector Therapy Experts

      Proactive Rash Management Vital for PI3K, AKT Inhibition in Breast Cancer

      Understanding How On-Target and Off-Target ADC Toxicities Work

      View More Latest Conference Coverage
      About Us
      Editorial Board
      Contact Us
      CancerNetwork.com
      CureToday.com
      OncLive.com
      TargetedOnc.com
      Advertise
      Privacy
      Terms & Conditions
      Do Not Sell My Information
      Contact Info

      2 Commerce Drive
      Cranbury, NJ 08512

      609-716-7777

      © 2025 MJH Life Sciences

      All rights reserved.